German biotechnology research group speeds up report:
This article was originally published in Clinica
A newly-established German technology advisory group is to produce its report on biotechnology by early autumn, rather than December as requested by Chancellor Helmut Kohl. The group consists of representatives from the academic, industrial and political spheres and will consider technology transfer and scientific progress, legislation concerning biotechnology, and general public acceptance of the concept. The group is the second to be set up since the Chancellor stressed the importance of biotechnology to Germany two years ago, says Nature (May 9th).
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.